FdaApplication
NDA 019614
Identifiers
- fda_app_no: NDA019614
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1990-05-29 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VERELAN | VERAPAMIL HYDROCHLORIDE | 240MG | CAPSULE, EXTENDED RELEASE;ORAL |
| VERELAN | VERAPAMIL HYDROCHLORIDE | 360MG | CAPSULE, EXTENDED RELEASE;ORAL |
| VERELAN | VERAPAMIL HYDROCHLORIDE | 180MG | CAPSULE, EXTENDED RELEASE;ORAL |
| VERELAN | VERAPAMIL HYDROCHLORIDE | 120MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products